• Prognostic Value of CV Biomarkers, End Points in Cancer Screening Trials, USPSTF on Breast Cancer Screening, and more

  • Jun 11 2024
  • Length: 12 mins
  • Podcast

Prognostic Value of CV Biomarkers, End Points in Cancer Screening Trials, USPSTF on Breast Cancer Screening, and more By cover art

Prognostic Value of CV Biomarkers, End Points in Cancer Screening Trials, USPSTF on Breast Cancer Screening, and more

Listen for free

View show details

  • Summary

  • Editor’s Summary by Mary McGrae McDermott, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the June 11, 2024, issue.
    Show more Show less
activate_primeday_promo_in_buybox_DT
Physical Illness & Disease Hygiene & Healthy Living Science
Show more Show less

What listeners say about Prognostic Value of CV Biomarkers, End Points in Cancer Screening Trials, USPSTF on Breast Cancer Screening, and more

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available